Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines.


Journal

Cancer treatment reviews
ISSN: 1532-1967
Titre abrégé: Cancer Treat Rev
Pays: Netherlands
ID NLM: 7502030

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 09 2020
revised: 02 04 2021
accepted: 11 04 2021
pubmed: 14 5 2021
medline: 29 6 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

Children and adolescents and young adults (AYAs) with cancer are often treated with a multidisciplinary approach. This includes use of radiotherapy, which is important for local control, but may also cause adverse events in the long term, including second cancer. The risks for limited growth and development, endocrine dysfunction, reduced fertility and second cancer in children and AYAs are reduced by proton beam therapy (PBT), which has a dose distribution that decreases irradiation of normal organs while still targeting the tumor. To define the outcomes and characteristics of PBT in cancer treatment in pediatric and AYA patients, this document was developed by the Japanese Society for Radiation Oncology (JASTRO) and the Japanese Society of Pediatric Hematology/Oncology (JSPHO).

Identifiants

pubmed: 33984606
pii: S0305-7372(21)00057-8
doi: 10.1016/j.ctrv.2021.102209
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102209

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Masashi Mizumoto (M)

Departments of Radiation Oncology, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Hiroshi Fuji (H)

Department of Radiology and National Center for Child Health and Development, Tokyo, Japan.

Mitsuru Miyachi (M)

Department of Pediatrics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.

Toshinori Soejima (T)

Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, Kobe, Hyogo, Japan.

Tetsuya Yamamoto (T)

Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.

Norihiro Aibe (N)

Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yusuke Demizu (Y)

Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, Kobe, Hyogo, Japan.

Hiromitsu Iwata (H)

Department of Radiation Oncology, Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya, Aichi, Japan.

Takayuki Hashimoto (T)

Department of Radiation Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

Atsushi Motegi (A)

Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.

Atsufumi Kawamura (A)

Department of Neurosurgery, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan.

Keita Terashima (K)

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Takashi Fukushima (T)

Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.

Tomohei Nakao (T)

Department of Pediatrics, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan.

Akinori Takada (A)

Department of Radiology, Mie University Hospital, Tsu-shi, Mie, Japan.

Minako Sumi (M)

Department of Radiation Oncology and Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Radiation Oncology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Junjiro Oshima (J)

Matsumoto Pediatrics, Sapporo, Hokkaido, Japan.

Kensuke Moriwaki (K)

Department of Medical Statistics, Kobe Pharmaceutical University, Kobe, Hyogo, Japan.

Miwako Nozaki (M)

Department of Radiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan.

Yuji Ishida (Y)

Department of Pediatrics, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan.

Yoshiyuki Kosaka (Y)

Department of Hematology and Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan.

Keisuke Ae (K)

Department of Orthopaedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

Ako Hosono (A)

Department of Pediatric Oncology, National Cancer Center Hospital East, Chiba, Japan.

Hideyuki Harada (H)

Division of Radiation Therapy, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan.

Etsuyo Ogo (E)

Department of Radiology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

Tetsuo Akimoto (T)

Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.

Takashi Saito (T)

Departments of Radiation Oncology, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Hiroko Fukushima (H)

Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Ryoko Suzuki (R)

Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Mitsuru Takahashi (M)

Department of Orthopaedic Oncology, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan.

Takayuki Matsuo (T)

Department of Neurosurgery, Nagasaki University Graduate School of Medicine, Nagasaki, Japan.

Akira Matsumura (A)

Departments of Neurosurgery, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Hidekazu Masaki (H)

Proton Therapy Center, Aizawa Hospital, Matsumoto, Nagano, Japan.

Hajime Hosoi (H)

Department of Pediatrics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.

Naoyuki Shigematsu (N)

Department of Radiology, Keio University School of Medicine, Tokyo, Japan.

Hideyuki Sakurai (H)

Departments of Radiation Oncology, University of Tsukuba, Tsukuba, Ibaraki, Japan. Electronic address: hsakurai@pmrc.tsukuba.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH